Home » Topics » BioWorld Science

BioWorld Science
RSS

WestVac BioPharma's COVID-19 vaccine shows high titer neutralizing antibodies against Omicron

Dec. 24, 2021

Evusheld retains neutralizing activity against Omicron variant

Dec. 24, 2021

Gene expression of extramedullary multiple myeloma samples points to new targets

Dec. 24, 2021

Anti-CD47 antibody ADG-153 shows promising preclinical data for cancer immunotherapy

Dec. 24, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 24, 2021

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

Dec. 24, 2021

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Dec. 24, 2021

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Alphataxin increases CD4+ tumor-infiltrating T cells and suppresses renal cell cancer in mice

Dec. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...